cerrar
Tagged with US

Top 10 Pharma Companies in Russia Ranking
The top 10 pharmaceutical companies in the Russian hospital market for the nine months up to November 2019, sorted by percentage share of total…

The US in 2020: Structural Constraints to Rein in Political…
Eurasia Group’s Aditya Bhattacharji examines the stalling of healthcare reforms in the US and what changes to US healthcare it is realistic to…

Matt Eyles – President & CEO, Association of…
Matt Eyles, president and CEO of the Association of Healthcare Insurance Providers (AHIP) outlines how the US health insurance landscape has evolved…

France Pharma Snapshot 2019
A snapshot of the latest data on the French pharmaceutical industry from industry association LEEM, including market revenues, R&D investments,…

FDA Drugs Approved in 2019
In 2019, the US FDA's Center for Drug Evaluation and Research approved 42 novel drugs, down from 59 drugs approved in 2018. Novartis had four drugs…

180-Day Exclusivity: The Key Ingredient in Hatch-Waxman
The AAM's Chip Davis looks back on 35 years of healthcare system savings from generic pharmaceuticals in the US, and the peril the generics industry…

Amendments to Russia’s Pharma Labeling Legislation: Uncertainty…
Nadezhda Fedotova and Andrey Zelenin of Lidings law firm gives an update on recent amendments to the labeling legislation for medicines in Russia,…

Want to Change Healthcare? Coalitions are Key
Carla Smith looks at the three vital components behind successful strategic alliances in US healthcare:disruption,  data-driven demands and…

Samir Khalil – Executive Director, PhRMA Middle East &…
Samir Khalil, executive director for the Pharmaceutical Research and Manufacturers of America (PhRMA) Middle East and Africa (MEA), reveals why the US…

The Fight Against Superbugs Heats Up
Boston University School of Law’s Kevin Outterson* looks at how cost-saving measures are contributing to the rise of drug-resistant “superbugs”…

The Role of Patient Associations in Rare Disease Drug Development
Monica Weldon, CEO and president of Bridge the Gap – SYNGAP Education and Research Foundation, shares her recent experience at the US Drug Law and…

Drug Shortages in Russia: An Increasing Concern
Russia is facing a drug shortage crisis which is having a particular impact on patients with life-threatening conditions. A combination of…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here